Allspring Global Investments
AUPH icon

Allspring Global Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

Allspring Global Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-595
Closed -$3.4K – 2461
2024
Q2 		$3.4K Sell
595
-697
-54% -$3.67K ﹤0.01% 2256
2024
Q1 		$6.47K Sell
1,292
-3,984
-76% -$27K ﹤0.01% 2175
2023
Q4 		$47.4K Sell
5,276
-95,430
-95% -$786K ﹤0.01% 1882
2023
Q3 		$782K Buy
100,706
+85,458
+560% +$836K ﹤0.01% 1424
2023
Q2 		$148K Buy
15,248
+15,132
+13,045% +$157K ﹤0.01% 1908
2023
Q1 		$1.27K Sell
116
-7,332
-98% -$64.6K ﹤0.01% 2733
2022
Q4 		$32.2K Sell
7,448
-163
-2% -$946 ﹤0.01% 2466
2022
Q3 		$57K Buy
+7,611
New +$65.9K ﹤0.01% 2299

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Allspring Global Investments's AUPH Position: Q3 2024 in Review

Allspring Global Investments sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2024, closing a stake of 595 shares — an estimated $3.4K sold.

Allspring Global Investments first reported a position in AUPH in Q3 2022 and held it in 8 quarters. The position peaked at $782K in Q3 2023. 183 funds tracked by Wall St. Rank hold AUPH as of Q3 2024.

  • Allspring Global Investments reported no remaining Aurinia Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 595 Aurinia Pharmaceuticals shares in Q3 2024, an estimated $3.4K.
  • Allspring Global Investments first reported a position in Aurinia Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • Allspring Global Investments's Aurinia Pharmaceuticals position peaked at $782K in Q3 2023.
  • 183 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.